Mainz Biomed Initiates Clinical Study to Evaluate Integrating Novel mRNA Biomarkers Into ColoAlert
Results to impact ColoAlert profile for FDA submission Provides opportunity for ColoAlert to achieve gold standard status as the premier...
News
Arcellx Announces Pricing of Initial Public Offering
GAITHERSBURG, Md., Feb. 04, 2022 (GLOBE NEWSWIRE) -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the...
Press Release: Strong 2021 sales and business EPS growth enabling increased investment in R&D
Strong 2021 sales and business EPS(1) growth enabling increased investment in R&D Paris, February 4, 2022 Q4 2021 sales growth...
Press Release: Strong 2021 sales and business EPS growth enabling increased investment in R&D
Strong 2021 sales and business EPS(1) growth enabling increased investment in R&D Paris, February 4, 2022 Q4 2021 sales growth...
Press release Biocartis Group NV: Disclosure of a transparency notification
PRESS RELEASE: REGULATED INFORMATION 4 February 2022, 07:00 CET Disclosure of a transparency notification Mechelen, Belgium, 4 February 2022 – Biocartis...
Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate
Dose selection complete for planned Phase 3 trial, expected to be initiated in 3Q2022Sub-analysis compared the immunogenicity of VLA15 in...
Orchard Therapeutics Announces Historic Agreement Making Libmeldy Available by NHS England for MLD Patients
First-ever lentiviral hematopoietic stem cell gene therapy approved for reimbursement by NHS England Two children with early-onset MLD recently treated...
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THIRD QUARTER ENDED DECEMBER 31, 2021 [UPDATED]
MINNEAPOLIS, MN, US, Feb. 03, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device...
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema,” “Olema Oncology” or the “Company,” Nasdaq: OLMA), a...
Free Dental and Vision Appointments for Uninsured Colorado Children as Part of National Give Kids A Smile Program
COLORADO SPRINGS, Colo., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Access to affordable dental services for children continues to be an...
Silk Road Medical to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
SUNNYVALE, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the...
Monte Rosa Therapeutics Announces Participation in Upcoming Investor Conferences
BOSTON, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology company developing novel molecular glue...
Arvinas to Present at Upcoming Investor Conferences
NEW HAVEN, Conn., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new...
PLx Pharma Inc. Proudly Celebrates Go Red for Women Day® 2022 to Support Heart Health Awareness
-- Female-Led Company Strives to Transform Standard of Care in Secondary Prevention of Heart Attack or Clot-Related Stroke with its Innovative New...
Results of Single Center Study on Delcath’s CHEMOSAT® Hepatic Delivery System Published in Melanoma Research
Retrospective Study by University Hospital Southampton in metastatic uveal melanoma (mUM) patients with liver dominant disease shows hepatic disease control...
SCYNEXIS Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
JERSEY CITY, N.J., Feb. 03, 2022 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to...
Beyond Air® Announces Two Appointments to Beyond Cancer™ Board of Directors
Mr. David Dvorak, previously the President and CEO of Zimmer Biomet, brings a 25+ year proven track record of executive...
Aligos Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company...
Sema4 to Participate at Two Upcoming Investor Conferences in February
STAMFORD, Conn., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company,...
IGM Biosciences to Present at the Guggenheim 2022 Oncology Conference
MOUNTAIN VIEW, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on...
